Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2021 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
huiying hu
(52 results)?
A novel fully human anti-NT-ANGPTL3 antibody from phage display library exhibits potent ApoB, TG, and LDL-C lowering activities in hyperlipidemia mice.
FASEB J. 2024 Jan;38(1):e23399. doi: 10.1096/fj.202301564RR.
FASEB J. 2024.
PMID: 38174870
Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy.
Xu M, Lei G, Chen M, Wang K, Lv W, Zhang P, Hu T, Gao J, Lu C, Mei Y, Xu Z, Bai Z, Hu H, Jiang Y, Tan S.
Xu M, et al. Among authors: hu h.
EBioMedicine. 2021 Mar;65:103250. doi: 10.1016/j.ebiom.2021.103250. Epub 2021 Feb 26.
EBioMedicine. 2021.
PMID: 33647772
Free PMC article.
Item in Clipboard
A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo.
Lei G, Xu M, Xu Z, Gu L, Lu C, Bai Z, Wang Y, Zhang Y, Hu H, Jiang Y, Zhao W, Tan S.
Lei G, et al. Among authors: hu h.
Int J Mol Sci. 2017 Sep 27;18(10):2064. doi: 10.3390/ijms18102064.
Int J Mol Sci. 2017.
PMID: 28953230
Free PMC article.
Item in Clipboard
Cite
Cite